MAPK3 and colonic neoplasm: According to our data, we propose that in colon tumor cells, ZP2 is expressed as a plasma membrane protein that, thereby, is capable as an upstream receptor and regulator of driving EXOSC5-ERK1/2-cyclinD1-signaling (Figure 7).